Pharmeco

Pharmeco, established in 2001, is a prominent Russian pharmaceutical holding company. It focuses on advancing high-technology development and fostering innovative production within the Russian Federation. Operating within the Pharmaceuticals and Healthcare sectors, Pharmeco has built a reputation for its commitment to technological progress and domestic manufacturing capabilities. The company's strategic direction emphasizes innovation, aiming to contribute significantly to the nation's pharmaceutical landscape.

With a revenue of $325.6M and employing between 1,000-5,000 individuals, Pharmeco demonstrates substantial operational scale. Despite having a single primary location, its impact is felt across the industry. The company's B2B focus underscores its role in the supply chain and its engagement with other businesses. The presence of directors in marketing and human resources suggests a structured organizational approach to growth and talent management. Meet Pharmeco's team to understand the leadership driving these initiatives.

Pharmeco's market presence is defined by its dedication to innovation and its position as a key player in the Russian pharmaceutical market. Its founding in 2001 signifies over two decades of experience and development in the sector. The company's hashtags indicate a B2B orientation and a focus on operational depth (#2_plus_operations). While specific financial details beyond revenue are not provided, its consistent operation and revenue suggest a stable and growing enterprise within the European healthcare ecosystem.